Bradley Foster & Sargent Inc. CT Acquires 400 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Bradley Foster & Sargent Inc. CT grew its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 4.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,756 shares of the company’s stock after acquiring an additional 400 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Henry Schein were worth $675,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Cromwell Holdings LLC boosted its holdings in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the period. Versant Capital Management Inc raised its position in shares of Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the last quarter. Venturi Wealth Management LLC raised its position in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after buying an additional 569 shares during the last quarter. Quent Capital LLC lifted its stake in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares during the period. Finally, City State Bank acquired a new stake in Henry Schein during the fourth quarter worth about $55,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on HSIC. Jefferies Financial Group upped their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Wells Fargo & Company assumed coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Eight analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $80.09.

Henry Schein Trading Down 1.0 %

Shares of HSIC stock opened at $77.24 on Friday. The company has a market capitalization of $9.63 billion, a P/E ratio of 31.79, a P/E/G ratio of 2.13 and a beta of 0.91. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a 50-day moving average price of $74.14 and a 200 day moving average price of $72.26.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.